| Literature DB >> 27493666 |
Mengrui Yang1, Min Wang1, Jian Zhou1, Yinqing Song1, Tongtong Wang1.
Abstract
Prior to preparation of CRM candidate of chloramphenicol in methanol with a concentration of 100 mg/L, two independent methods including mass balance (MB) and quantitative nuclear magnetic resonance (qNMR) were employed to precisely measure the mass fraction of pure chloramphenicol materials. The mass fraction was assigned to be 99.8% with uncertainty of 0.3%. Homogeneity testing and stability study of chloramphenicol in methanol were examined by using high performance liquid chromatography. Additionally, the uncertainties originating from the process of CRM development were comprehensively evaluated. The experimental results indicate that the property value of this CRM is homogeneous and stable at 4°C for at least six months. The new CRM (GBW(E)082557) can be applicable to calibration of instrument and assurance of accuracy and comparability of results in routine measurement.Entities:
Year: 2016 PMID: 27493666 PMCID: PMC4961862 DOI: 10.1155/2016/2348257
Source DB: PubMed Journal: Int J Anal Chem ISSN: 1687-8760 Impact factor: 1.885
Figure 1The H-NMR spectra of (a) internal standard (ethyl paraben and methanol-D4) and (b) sample solution (chloramphenicol, ethyl paraben, and methanol-D4).
Mass fraction of chloramphenicol calculated with different pointed signal peaks (n = 7).
| Pairs | Peak of | Peak of | Mean of | SD/% |
|---|---|---|---|---|
| A | d | F′ | 99.82 | 0.07 |
| B | c | F′ | 99.13 | 0.09 |
| C | a | A′ | 98.94 | 0.05 |
“n” means different data sets measured under the same conditions.
Figure 2Baseline enlarged H-NMR spectrum of sample solution (chloramphenicol, ethyl paraben, and methanol-D4).
Figure 3Chromatography of (a) methanol blank, (b) 100 mg/L chloramphenicol in methanol, and (c) 2000 mg/L chloramphenicol in methanol.
Mass fraction of chloramphenicol measured by MB methods.
| Sample vials number | HPLC/% | Moisture/% | Purity/% |
|---|---|---|---|
| 1 | 99.87 | 0.020 | 99.85 |
| 2 | 99.84 | 0.030 | 99.81 |
| 3 | 99.84 | 0.026 | 99.81 |
| 4 | 99.87 | 0.025 | 99.85 |
| 5 | 99.83 | 0.028 | 99.80 |
| 6 | 99.83 | 0.023 | 99.81 |
| 7 | 99.82 | 0.024 | 99.80 |
| Mean | 99.84 | 0.025 | 99.82 |
| SD | 0.020 | 0.003 | 0.02 |
Data of homogeneity study.
| Vials number | Peak area | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | Mean | SD | |
| 1 | 3377539 | 3455815 | 3426396 | 3419917 | 39538 |
| 2 | 3363161 | 3383494 | 3413952 | 3386869 | 25563 |
| 3 | 3373464 | 3438840 | 3444717 | 3419007 | 39551 |
| 4 | 3361335 | 3400715 | 3431809 | 3397953 | 35318 |
| 5 | 3361386 | 3385011 | 3400994 | 3382464 | 19926 |
| 6 | 3370750 | 3440166 | 3441286 | 3417401 | 40405 |
| 7 | 3396404 | 3442398 | 3445094 | 3427965 | 27366 |
| 8 | 3412038 | 3456559 | 3452226 | 3440274 | 24549 |
| 9 | 3492616 | 3414137 | 3400516 | 3435756 | 49711 |
| 10 | 3412637 | 3423430 | 3431176 | 3422414 | 9311 |
| 11 | 3382569 | 3410793 | 3415548 | 3402970 | 17827 |
| 12 | 3351945 | 3362416 | 3401855 | 3372072 | 26319 |
| 13 | 3359186 | 3400385 | 3432492 | 3397354 | 36747 |
| 14 | 3363789 | 3419854 | 3419894 | 3401179 | 32381 |
| 15 | 3373310 | 3417544 | 3432514 | 3407789 | 30784 |
| 16 | 3377488 | 3418379 | 3415865 | 3403911 | 22917 |
| 17 | 3382255 | 3412441 | 3413938 | 3402878 | 17876 |
| 18 | 3393284 | 3425055 | 3415432 | 3411257 | 16292 |
| 19 | 3406204 | 3444518 | 3444612 | 3431778 | 22148 |
| 20 | 3403316 | 3406961 | 3405709 | 3405329 | 1852 |
| 21 | 3364827 | 3408684 | 3409946 | 3394486 | 25693 |
| 22 | 3382216 | 3383257 | 3405014 | 3390162 | 12872 |
| 23 | 3400230 | 3387406 | 3414257 | 3400631 | 13430 |
| 24 | 3361051 | 3391923 | 3404463 | 3385812 | 22342 |
| 25 | 3353175 | 3403030 | 3394614 | 3383606 | 26688 |
Results of homogeneity study.
| Items | Results |
|---|---|
| Total mean | 3405649 |
| Total SD | 28716 |
| Between-bottle | 946997904 |
| Within-bottle | 765842476 |
|
|
|
|
|
|
| Evaluation result |
|
Result of short-term stability study.
| Time/day | Value/(mg/L) | |
|---|---|---|
| Condition/20°C | Condition/40°C | |
| 0 | 100.7 | 100.7 |
| 2 | 100.2 | 99.8 |
| 4 | 100.0 | 96.4 |
| 6 | 99.4 | 93.3 |
| 8 | 99.9 | 92.4 |
|
| ||
| Mean | 99.8 | 96.6 |
|
| ||
|
| −0.119 | −1.153 |
|
| 100.5 | 101.1 |
|
| 0.1053 | 0.7423 |
|
| 0.0513 | 0.1362 |
|
| 3.18 | 3.18 |
| Conclusion | | | | |
Results of long-term stability study.
| Time/month | Value/(mg/L) | |||
|---|---|---|---|---|
| 0 | 1 | 3 | 6 | |
| #1 | 100.4 | 100.4 | 101.4 | 100.2 |
| 101.2 | 99.7 | 100.9 | 99.8 | |
| 101.1 | 99.6 | 101.0 | 100.5 | |
|
| ||||
| #2 | 100.2 | 99.1 | 100.5 | 100.3 |
| 101.6 | 101.4 | 100.3 | 99.9 | |
| 100.8 | 100.8 | 100.6 | 99.8 | |
|
| ||||
| Mean | 100.9 | 100.2 | 100.8 | 100.1 |
|
| ||||
|
| −0.0845 | |||
|
| 100.7 | |||
|
| 0.1801 | |||
|
| 0.0926 | |||
|
| 4.3 | |||
| Conclusion | | | |||
Figure 4Uncertainty sources in the development process of chloramphenicol in methanol CRM.
Results of uncertainty.
| Items | Assessment and calculation | Results |
|---|---|---|
|
| (1) variability of balance measurement (empirical estimation) | 0.41% |
| (2) uncertainty of balance calibration (metrological verification certificate) | ||
|
| ||
|
| (1) error of volumetric flask (metrological verification certificate) | 0.35% |
| (2) random error (empirical estimation) | ||
| (3) variation with temperature (calculation) | ||
|
| ||
|
|
| 0.28% |
|
| ||
|
|
| 0.61% |
|
| ||
|
|
| 0.23% |
|
| ||
|
|
| 0.56% & 0.41% |
|
| ||
|
|
| 0.94% |
|
| ||
|
|
| 2 mg/L |
Verification results of chloramphenicol in methanol CRM (unit: mg/L).
| Item | Measured value | Assigned value | ||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | Mean | SD | ||
| CRM | 99.5 | 99.9 | 99.7 | 99.7 | 0.2 | 100 ± 2 |